Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial.
Williams CJM, Gray R, Hills RK, Shires M, Zhang L, Zhao Z, Gardner T, Sapanara N, Xu XM, Bai I, Yan D, Muranyi A, Dance S, Aghaei F, Hemmings G, Hale M, Kurkure U, Guetter C, Richman SD, Hutchins G, Seligmann JF, West NP, Singh S, Shanmugam K, Quirke P.
Williams CJM, et al. Among authors: hutchins g.
J Clin Oncol. 2024 Oct 10;42(29):3430-3442. doi: 10.1200/JCO.23.02030. Epub 2024 Jul 31.
J Clin Oncol. 2024.
PMID: 39083705
Free PMC article.
Clinical Trial.